Navigation Links
NDIS Approval of the Promega PowerPlex(R) Y23 System Enables More Usable Profiles in Less Time
Date:2/5/2013

Madison, WI (PRWEB) February 05, 2013

The Promega PowerPlex® Y23 System is now approved for use in laboratories that generate DNA records for the National DNA Index System (NDIS). NDIS is the US national database containing over ten million offender profiles used to help authorities in solving criminal investigations nationwide.

Launched in July 2012, the PowerPlex Y23 System is a rapid human identification Y-chromosome short tandem repeat (Y-STR) assay for forensic casework, offender databasing and relationship testing. Thermal cycling time is cut roughly in half, and the system detects substantially more Y-STR loci than current systems. The multiplex system co-amplifies 23 Y-STR loci, providing maximum discrimination. In addition, these 23 loci include all of the Y-STR loci found in key public STR databases in the US and Europe.

The system works with extracted DNA, including DNA from difficult samples with lower amounts of template and male:female mixtures. Streamlined protocols are provided for all sample types. The combination of reduced sample preparation time and shorter cycling times results in a significant reduction in total time to process samples. For many laboratories, this will save more than a half day per plate.

The additional loci and increased haplotype resolution improve scientists’ ability to distinguish individuals from different paternal lines. The PowerPlex Y23 System is useful in multiple applications, including paternity testing, offender databasing and forensic casework such as sexual assault cases, missing persons investigations and familial searching initiatives.

PowerPlex is a registered trademark of Promega Corporation.

Promega Corporation has provided products for DNA-based human identification for over 20 years. Promega is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,500 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit http://www.promega.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10394137.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
2. Watsons Generic Yaz(R) Receives FDA Approval
3. ThermoGenesis Announces Approval of AXP® by India Ministry of Health
4. FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length
5. Nautilus Neurosciences, Inc. Announces a New Approval for CAMBIA® for the Acute Treatment of Migraine
6. Watsons Generic BONIVA® 150mg Receives FDA Approval
7. Arteriocyte Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention Focused on Wounded Warriors
8. Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities
9. FDA Issues Orphan Status Approval for PermaDerm®
10. West Wireless Health Institute Applauds House Passage of Bill to Streamline FDA Medical Device Approval Process, Expedite Mobile Medical App Guidance
11. Lupin Receives FDA Approval for Generic LYRICA(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology:
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):